NEW YORK (GenomeWeb News) – Becton Dickinson today reported fourth-quarter 2009 revenue growth of 5 percent, or 8 percent excluding the negative effects of currency translation, driven by strong sales for its BD Medical and BD Diagnostics segments.

BD brought in total revenues of $ 1.9 billion for the three-month period ended Sept. 30, compared to $1.8 billion for the fourth quarter of 2008. The firm beat analysts' consensus estimate of $1.85 billion.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

This year's Breakthrough Prize winners include a pair that developed a therapy for spinal muscular atrophy.

The New York Times reports on how white supremacists misconstrue genetic research, concerning many geneticists.

Researchers find that people's genetics influence their success at university, but that it is not the only factor.

In Nature this week: approach to identify genetic variants that affect trait variability, application of read clouds to microbiome samples, and more.